Certified by Founder Lodge 
                                        
                                        Enavate Sciences
 
                                                 United States  -  ND 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $100,000,000
                                            6 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Enavate Sciences is a platform dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient need. Through the a
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   CAMP4 Therapeutics | 
                                                            July, 20 ,2022 | Series B | $100,000,000 | 
   OrsoBio | 
                                                            November, 08 ,2023 | Series A | $60,000,000 | 
   Sudo Biosciences | 
                                                            December, 21 ,2023 | Series B | $116,000,000 | 
   Sionna Therapeutics | 
                                                            March, 07 ,2024 | Series C | $182,000,000 | 
   Aviceda Therapeutics | 
                                                            January, 08 ,2025 | Series C | $207,500,000 | 
   Normunity | 
                                                            January, 14 ,2025 | Series B | $75,000,000 | 
                                                
  CAMP4 Therapeutics
  OrsoBio
  Sudo Biosciences
  Sionna Therapeutics
  Aviceda Therapeutics
  Normunity
Patchwork Health
 
                                            
Abridge
Salvo Health
CareBridge
Health Note
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)